Studies on hemostasis in COVID‐19 deserve careful reporting of the laboratory methods, their significance, and their limitations

We read with much interest the recent observational study of Nougier et al., which aimed at studying thrombin generation (TG) and fibrinolysis profiles of COVID-19 patients admitted to an intensive care unit (ICU) or to an internal medicine ward and receiving various schemes of prophylactic heparin.[1] They reported that thrombin potential remained within normal range despite heparin and that fibrinolysis was decreased in relation with increased plasminogen activator inhibitor 1 (PAI-1) and thrombin-activatable fibrinolysis inhibitor (TAFI) antigen plasma levels. Using the rotational thromboelastometry (ROTEM) delta device with EXTEM reagents and the addition of 0.625µg/mL tPA (referred to as 'TEM-tPA'), they reported decreased clot lysis in COVID-19 patients, which was more pronounced in patients who presented a thrombotic event, compared to event-free patients.

[1]  G. Lippi,et al.  Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory , 2020, Thrombosis Journal.

[2]  P. Myles,et al.  Fibrinolysis and COVID‐19: A tale of two sites? , 2020, Journal of Thrombosis and Haemostasis.

[3]  L. Argaud,et al.  Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis , 2020, Journal of Thrombosis and Haemostasis.

[4]  N. Guzzetta,et al.  Not just small adults: Considering the impact of developmental hemostasis on neonatal extracorporeal circulation , 2020, Journal of thrombosis and haemostasis : JTH.

[5]  F. V. D. van der Meer,et al.  Quality performance for indirect Xa inhibitor monitoring in patients using international external quality data , 2020, Clinical chemistry and laboratory medicine.

[6]  M. Ranucci,et al.  Sensitivity of Viscoelastic Tests to Platelet Function , 2020, Journal of clinical medicine.

[7]  E. Weiss,et al.  New insights into neonatal coagulation: normal clot formation despite lower intra-clot thrombin levels , 2019, Pediatric Research.

[8]  M. Siepe,et al.  Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support. , 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  J. Dogné,et al.  Assessment of the analytical performances and sample stability on ST Genesia system using the STG‐DrugScreen application , 2019, Journal of thrombosis and haemostasis : JTH.

[10]  B. Zieger,et al.  Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  J. Thachil,et al.  A re‐evaluation of the D‐dimer cut‐off value for making a diagnosis according to the ISTH overt‐DIC diagnostic criteria: communication from the SSC of the ISTH , 2018, Journal of thrombosis and haemostasis : JTH.

[12]  R. van Oerle,et al.  Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity , 2016, Thrombosis Journal.

[13]  E. Duncan,et al.  Evaluation of pre-analytical variables in a commercial thrombin generation assay. , 2014, Thrombosis research.

[14]  B. Rinner,et al.  Microparticles in newborn cord blood: slight elevation after normal delivery. , 2011, Thrombosis research.

[15]  H. Köfeler,et al.  Phospholipid content, expression and support of thrombin generation of neonatal platelets , 2008, Acta paediatrica.

[16]  D. Atsma,et al.  Development of a new test for the global fibrinolytic capacity in whole blood , 2007, Journal of thrombosis and haemostasis : JTH.

[17]  W. Muntean,et al.  Low tissue factor pathway inhibitor (TFPI) together with low antithrombin allows sufficient thrombin generation in neonates , 2003, Journal of thrombosis and haemostasis : JTH.

[18]  P. Powers,et al.  Development of the human coagulation system in the full-term infant. , 1987, Blood.